Keli Walbert

Keli Walbert

Director/Board Member at SPRUCE BIOSCIENCES, INC.

Net worth: - $ as of 31/08/2026

59 year
Health Technology
Consumer Services

Profile

Ms. Keli Walbert is an Independent Director at Spruce Biosciences, Inc. She is on the Board of Directors at Hemab Therapeutics Holdings, Inc. and Spruce Biosciences, Inc. Ms. Walbert was previously employed as an Independent Director by Apellis Pharmaceuticals, Inc. and an Executive Vice President-US Commercial by Horizon Therapeutics Ltd. (Ireland).
She received her undergraduate degree from the University of Louisville and a graduate degree from Northwestern University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
21/05/2026 0 ( -.--% ) - $ 31/08/2026
24/09/2026 0 ( -.--% ) - $ 31/08/2026

Keli Walbert active positions

CompaniesPositionStart
SPRUCE BIOSCIENCES, INC. Director/Board Member 11/12/2025
HEMAB THERAPEUTICS HOLDINGS, INC. Director/Board Member 24/09/2026

Former positions of Keli Walbert

CompaniesPositionEnd
APELLIS PHARMACEUTICALS, INC. Director/Board Member 14/05/2026
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Corporate Officer/Principal 01/01/2023
See the detail of Keli Walbert's experience

Training of Keli Walbert

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology